What You Need to Know First

Persistent back pain after spinal surgery is a documented clinical phenomenon. When a prior procedure has not delivered lasting relief, biologic disc repair—specifically intra-annular fibrin injection—is a non-surgical option designed to address annular tears and disc damage that surgery may have left unresolved. A clinical evaluation is the only way to know for certain whether it fits your situation.

Is Ongoing Pain After Back Surgery a Sign That Something Was Missed?

Not always—but often, yes. When pain persists or returns after a spinal procedure, it frequently points to disc-level pathology that was not fully resolved.

Spinal surgery addresses specific structural problems: a herniated fragment pressing on a nerve, instability requiring fusion, or spinal canal narrowing. What surgery does not always address is the underlying annular tear—the breach in the disc wall that allows inflammatory material to leak and sensitize surrounding nerve tissue. If that tear remains, pain can return even after a technically successful operation.

This pattern is common enough to have a clinical name: Failed Back Surgery Syndrome (FBSS). Learn more about FBSS causes, symptoms, and recovery options. Back surgery carries roughly a 40% failure rate in long-term outcomes studies, making post-surgical pain one of the most frequently encountered presentations in spine care today.

What Does Your Post-Surgical Imaging Actually Show?

Updated imaging taken after your procedure is the starting point for any honest evaluation of what is driving your current pain.

Pre-operative MRIs document what existed before surgery. Post-operative imaging tells a different story: whether the original pathology was fully addressed, whether new disc changes have developed at adjacent levels, and whether annular tears are present that were not the surgical target. Key findings to look for include:

  • Annular tears — breaches in the outer disc wall that can cause discogenic pain
  • Adjacent segment disease — accelerated degeneration at levels above or below a fusion, a recognized complication of spinal fusion surgery. See a plain-English explanation of adjacent segment disease.
  • Continued disc degeneration — breakdown of disc tissue that was not the focus of the original surgery
  • Residual or recurrent disc herniation — herniated material that reformed or was incompletely removed

An annulogram—an imaging-guided diagnostic procedure—goes further than standard MRI by identifying every tear and leak point across the affected discs before any treatment decision is made. This diagnostic step is central to how the Valor team evaluates post-surgical patients.

How Does Your Full Treatment History Shape the Decision?

The path to candidacy for biologic disc repair runs through a complete review of every treatment tried and how each one performed.

For patients presenting after failed surgery, the clinical team needs to understand not just the surgery itself, but the full arc of care: physical therapy, epidural steroid injections, oral medications, chiropractic treatment, spinal decompression, and any other interventions attempted before or after the operation. Duration, intensity, and outcome matter for each.

It is worth noting what the evidence shows about common conservative treatments. An AAFP systematic review found epidural steroid injections are not effective for chronic low back pain. Spinal decompression shows sustained improvement in roughly 36.8% of cases at six months. PRP achieves 50% or greater pain relief in approximately 47% of patients at six months. These are population-level statistics—individual outcomes vary—but they underscore why post-surgical patients who have exhausted standard options are evaluating what else exists.

Explore a structured framework for evaluating non-surgical disc repair when surgery has not worked.

What Is Biologic Disc Repair and How Is It Different from Surgery?

Biologic disc repair is designed to seal damaged disc tissue rather than remove or immobilize it.

Intra-annular fibrin injection uses an FDA-approved fibrin sealant, delivered under imaging guidance through a thin catheter, directly into the affected disc. The procedure takes under an hour, requires no incisions, and is performed under local anesthesia or light sedation. The fibrin sealant is intended to seal annular tears, reduce inflammatory leakage, and create the structural conditions that allow the disc to stabilize and heal over time.

This is a fundamentally different mechanism than discectomy (which removes herniated material) or fusion (which immobilizes a spinal segment). For patients whose pain originates from disc-level pathology that was not resolved by their prior procedure, a treatment that addresses the disc wall directly represents a distinct clinical pathway—not a repeat of what already failed.

Among the most-tracked outcomes in the published registry—over 7,000 procedures with long-term follow-up—the reported success rate is 83%. Among patients who had previously undergone spinal surgery, 80% reported positive outcomes with fibrin injection. Individual outcomes vary, and a clinical evaluation is the only way to assess what these figures may mean for a specific patient’s situation.

Clinical Note

Patients who come to us after a prior surgery often carry a particular kind of exhaustion—not just physical, but the emotional weight of having tried the thing that was supposed to fix it. What we find, consistently, is that the disc tear was there before the surgery and remained after it. The annulogram makes that visible. When patients see the imaging evidence of what’s actually generating their pain, it changes the conversation from ‘why am I still hurting?’ to ‘here is what we can address.’ That clarity matters before any treatment decision is made.

What Goals and Expectations Are Realistic Going In?

Patients who enter evaluation with clear, grounded goals have better-quality consultations and more informed decisions about whether to proceed.

Biologic disc repair is designed to reduce discogenic pain, improve function, and avoid further surgery—not to produce immediate or dramatic transformation. The healing process following intra-annular fibrin injection is gradual. Changes in pain levels and functional capacity typically develop over weeks to months as the disc stabilizes. For patients whose primary objective is to address the structural source of their pain without another operation, and who understand that biological healing takes time, the expectations and the procedure’s design are well-matched.

For patients exploring the post-surgical path more broadly, this guide on finding lasting relief for post-surgical pain covers the decision landscape in detail.

What Does the Evaluation Process Actually Look Like?

Candidacy for fibrin disc treatment is determined through a structured clinical evaluation—not a self-assessment checklist.

The evaluation process at Valor begins with a no-cost consultation and MRI review. The clinical team assesses your imaging, your surgical history, and your symptom pattern to determine whether disc-level pathology is the likely driver of your current pain. If the initial evaluation supports candidacy, an annulogram is performed to precisely identify every tear and leak point before any treatment is planned.

This two-step approach—diagnostic clarity before treatment—is what distinguishes a well-designed evaluation from a generic treatment recommendation. See how to get answers for post-surgery back pain through a structured evaluation.

For patients who have had fusion surgery and are experiencing pain at adjacent levels, this case study illustrates how fibrin disc repair has been used in adjacent segment disease after fusion.

Frequently Asked Questions

Can someone who has already had back surgery be a candidate for biologic disc repair?

Prior surgery does not automatically exclude a patient from candidacy. The clinical evaluation focuses on whether active disc-level pathology—specifically annular tears—is present and driving the current pain. Among patients with a prior surgery history, 80% reported positive outcomes with fibrin injection in outcome registry data, though individual outcomes vary.

What is Failed Back Surgery Syndrome and how does it connect to disc repair?

Failed Back Surgery Syndrome (FBSS) refers to persistent or recurrent back pain following a spinal procedure that was expected to resolve it. In many FBSS cases, the underlying annular tear was not the surgical target and remains present after the operation. Biologic disc repair is specifically designed to address that unresolved disc pathology. Learn more about FBSS and its treatment options.

What imaging do I need before a consultation?

An existing lumbar or cervical MRI is the starting point—the Valor team offers a no-cost MRI review. Post-surgical imaging is especially informative. If the initial review supports further evaluation, an annulogram is used to precisely map disc tears before any treatment decision is finalized.

What is an annulogram and why does it matter for post-surgical patients?

An annulogram is an imaging-guided diagnostic procedure that identifies every tear and leak point within the affected discs. For post-surgical patients, it is particularly important because standard MRI may not fully capture the disc-wall pathology driving current pain. The annulogram confirms which discs are symptomatic before treatment is planned.

How long does recovery from intra-annular fibrin injection take?

Recovery is gradual. The fibrin sealant initiates a biological healing process that unfolds over weeks to months. Most patients do not experience immediate dramatic relief; meaningful improvements in pain and function typically develop progressively as the disc stabilizes. Specific timelines depend on individual patient factors and clinical findings.

Is the fibrin sealant used in the procedure FDA-approved?

The fibrin sealant used in the procedure is FDA-approved as a sealant (manufactured by Baxter Pharmaceuticals). Specific clinical applications, candidacy, and outcomes vary by patient.

What if my pain is at a level adjacent to a previous fusion?

Adjacent segment disease—accelerated degeneration at levels above or below a fusion—is a recognized complication of spinal fusion. When disc-level pathology is identified at adjacent segments, biologic disc repair may be an option worth evaluating. See a detailed explanation of adjacent segment disease and an illustrative case of fibrin treatment in a post-fusion patient. A clinical evaluation is the only way to know whether candidacy applies in a specific situation.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.

Schedule appointment

Let’s Get Social